Progress and prospective of plant sterol and plant stanol research: Report of the Maastricht meeting

Atherosclerosis

Volumn 225, Issue 2, 2012, Pages 521-533

  Plat, J ^a   Mackay, D ^b   Baumgartner, S ^c   Clifton, P M ^d   Gylling, H ^e   Jones, P J H ^b   Awad, Atif ^f   Chapman, John ^g   Baker, Peter Clifton ^h   Gylling, Helena ^d   Lutjohann, Dieter ⁱ   Marz, Winfried ^j   Moreau, Bob ^k   Ostlund, Richard ^l   Plat, Jogchum ^a   Rideout, Todd ^f   Ros, Emilio ^m   Schaefer, Ernst ⁿ   Daniel, Teupser ^o   Vartiainen, Erkki ^p   Weingartner, Oliver ^q   Zampelas, Antonis ^r   Berger, Alvin ^s   Wester, Ingmar ^s   Rosin, Susanna ^s   Meijer, Gert ^t   Trautwein, Elke ^t   Ras, Rouyanne ^t   Antoine, Jean Michel ^s   Jeansen, Stephanie ^s   Koutnikova, Hana ^s   Short, Collette ^s   Messinger, Horst ^u   Horlacher, Peter ^u   Ehrhardt, Christina ^u   Brañes, Cecilia ^s   Harting, Thomas ^s   Thompson, Gilbert ^v   Tikkanen, Matti ^d   Shaghaghi, Mandana Amir ^b   Baer, David ^w   Ansorena, Diana ^x   Baumgartner, Sabine ^a   Blanco Vaca, Francisco ^y   Ellegard, Lars ^z   Carles, Joan ^y   Laitinen, Kirsi ^aa   Myrie, Semone ^b   Miettinen, Tatu ^d   Mymin, David ^ab   Robinson, Matthew ^ac   Rompelberg, Cathy ^ad   Sarkkinen, Essi ^ae   Silbernagel, Guenther ^af   de Smet, Els ^a   Loman, Stoffer ^ag   more..

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF MANITOBA   (Canada)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^d UNIVERSITY OF HELSINKI   (Finland)

^e UNIVERSITY OF EASTERN FINLAND   (Finland)

^f UNIVERSITY AT BUFFALO   (United States)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^h Baker IDI Heart and Diabetes Research Institute   (Australia)

ⁱ UNIVERSITY OF BONN   (Germany)

^j SYNLAB ACADEMY   (Germany)

^k EASTERN REGIONAL RESEARCH CENTER   (United States)

^l WASHINGTON UNIVERSITY   (United States)

^m Lipid Clinic   (Spain)

ⁿ TUFTS UNIVERSITY   (United States)

^o UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^p NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^q SAARLAND UNIVERSITY   (Germany)

^r AGRICULTURAL UNIVERSITY OF ATHENS   (Greece)

^s National Public Health Institute ^*

^t UNILEVER   (Netherlands)

^u BASF   (Germany)

^v HAMMERSMITH HOSPITAL   (United Kingdom)

^w BELTSVILLE HUMAN NUTRITION RESEARCH CENTER   (United States)

^x UNIVERSITY OF NAVARRA   (Spain)

^y BIOMEDICAL RESEARCH INSTITUTE SANT PAU IIB SANT PAU   (Spain)

^z UNIVERSITY OF GOTHENBURG   (Sweden)

^aa UNIVERSITY OF TURKU   (Finland)

^ab HEALTH SCIENCES CENTRE   (Canada)

^ac ExCLAIM International   (Netherlands)

^ad NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^ae FoodFiles Ltd   (Finland)

^af UNIVERSITY OF TÜBINGEN   (Germany)

^ag NutriClaim   (Netherlands)

more..

Author keywords

Cholesterol; Nutrition; Plant stanols; Plant sterols

Indexed keywords

ANTILIPEMIC AGENT; ANTINEOPLASTIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHYTOSTEROL; PLANT STANOL; STANOZOLOL; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANTINEOPLASTIC ACTIVITY; ATHEROSCLEROSIS; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; CONSENSUS DEVELOPMENT; DRUG EFFICACY; DRUG FORMULATION; FOOD INTAKE; HUMAN; LIPID METABOLISM; NETHERLANDS; NONHUMAN; PRIORITY JOURNAL;

EID: 84944443373     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.09.018     Document Type: Article

References (145)

1. Katan M.B., Grundy S.M., Jones P., et al. Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc 2003, 78:965-978.
2. NCEP Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 2002, 106:3143-3421.
3. Lichtenstein A.H., Deckelbaum R.J. AHA Science Advisory. Stanol/sterol ester-containing foods and blood cholesterol levels. A statement for healthcare professionals from the nutrition committee of the council on nutrition, physical activity, and metabolism of the American heart association. Circulation 2001, 103:1177-1179.
4. EFSA Scientific opinion of the panel on dietetic products nutrition and allergies on a request from unilever PLC/NV on plant sterols and lower/reduced blood cholesterol, reduced the risk of (coronary) heart disease. EFSA J 2008, 781:1-12.
5. EFSA Scientific opinion of the panel on dietetic products, nutrition and allergies on a request from McNeil nutritionals Ltd. related to the scientific substantiation of a health claim on plant stanol esters and lower/reduced blood cholesterol and reduced risk of (coronary) heart disease. EFSA J 2008, 825:1-13.
6. EFSA Scientific opinion of the panel on dietetic products nutrition and allergies on a request from the European commission and a similar request from France in relation to the authorization procedure for health claims on plant sterols/stanols and lowering/reducing blood LDL-cholesterol pursuant to Article 14 of Regulation (EC) No 1924/2006. EFSA J 2009, 1175.
7. EFSA EFSA panel on dietetic products, nutrition and allergies (NDA); scientific opinion on the substantiation of a health claim related to 3 g/day plant sterols/stanols and lowering blood LDL-cholesterol and reduced risk of (coronary) heart disease pursuant to article 19 of regulation (EC) No 1924/2006. EFSA J 2012, 10(5):2693.
8. EFSA EFSA panel on dietetic products, nutrition and allergies (NDA); scientific opinion on the substantiation of a health claim related to 3 g/day plant stanols as plant stanol esters and lowering blood LDL-cholesterol and reduced risk of (coronary) heart disease pursuant to article 14 of regulation (EC) No 1924/2006. EFSA J 2012, 10(5):2692.
9. Cholesterol treatment trial lists collaboration Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. The Lancet 2010, 376:1670-1681.
10. LaRosa J.C. Low-density lipoprotein cholesterol reduction: the end is more important than the means. Am J Cardiol 2007, 100:240-242.
11. Law M.R., Wald N.J., Rudnicka A.R. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ 2003, 326:1423.
12. Catapano A.L., Reiner Z., De Backer G., et al. ESC/EAS guidelines for the management of dyslipidaemias the task force for the management of dyslipidaemias of the European society of cardiology (ESC) and the European atherosclerosis society (EAS). Atherosclerosis 2011, 217:3-46.
13. Perk J., De Backer G., Gohlke H., et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012): the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Atherosclerosis 2012, 223:1-68.
14. Ostlund R.E. Phytosterols in human nutrition. Annu Rev Nutr 2002, 22:533-549.
15. Chan Y.M., Varady K.A., Lin Y., et al. Plasma concentrations of plant sterols: physiology and relationship with coronary heart disease. Nutr Rev 2006, 64:385-402.
16. Gylling H., Miettinen T.A. The effects of plant stanol ester in different subject groups. Eur Cardiol 2010, 6:18-21.
17. Plat J., Mensink R.P. Plant stanol and sterol esters in the control of blood cholesterol levels: mechanism and safety aspects. Am J Cardiol 2005, 96:15D-22D.
18. Plat J., Mensink R.P. Effects of plant stanol esters on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase mRNA expression in mononuclear blood cells of healthy men and women. FASEB J 2002, 16:258-260.
19. Smet E.D., Mensink R.P., Plat J. Effects of plant sterols and stanols on intestinal cholesterol metabolism: suggested mechanisms from past to present. Mol Nutr Food Res 2012, 56(7):1058-1072.
20. Abumweis S.S., Barake R., Jones P.J. Plant sterols/stanols as cholesterol lowering agents: a meta-analysis of randomized controlled trials. Food Nutr Res 2008, 52.
21. Demonty I., Ras R.T., van der Knaap H.C., et al. Continuous dose-response relationship of the LDL-cholesterol-lowering effect of phytosterol intake. J Nutr 2009, 139:271-284.
22. Mensink R.P., de Jong A., Lutjohann D., et al. Plant stanols dose-dependently decrease LDL-cholesterol concentrations, but not cholesterol-standardized fat-soluble antioxidant concentrations, at intakes up to 9 g/d. Am J Clin Nutr 2010, 92:24-33.
23. Gylling H., Hallikainen M., Nissinen M.J., et al. The effect of a very high daily plant stanol ester intake on serum lipids, carotenoids, and fat-soluble vitamins. Clin Nutr 2010, 29:112-118.
24. Clifton P.M., Noakes M., Ross D., et al. High dietary intake of phytosterol esters decreases carotenoids and increases plasma plant sterol levels with no additional cholesterol lowering. J Lipid Res 2004, 45:1493-1499.
25. Davidson M.H., Maki K.C., Umporowicz D.M., et al. Safety and tolerability of esterified phytosterols administered in reduced-fat spread and salad dressing to healthy adult men and women. J Am Coll Nutr 2001, 20:307-319.
26. Musa-Veloso K., Poon T.H., Elliot J.A., et al. A comparison of the LDL-cholesterol lowering efficacy of plant stanols and plant sterols over a continuous dose range: results of a meta-analysis of randomized, placebo-controlled trials. Prostaglandins Leukot Essent Fatty Acids 2011, 85:9-28.
27. Demonty I., Ras R.T., Trautwein E.A. Comment on: "A comparison of the LDL-cholesterol lowering efficacy of plant stanols and plant sterols over a continuous dose range: results of a meta-analysis of randomized, placebo controlled trials" by Musa-Veloso K et al. Prostagl Leucot Essent Fatty Acids 2011, 85:9-28. Prostaglandins Leukot Essent Fatty Acids, 2011;85:7-8.
28. Maki K.C., Rains T.M. Hypocholesterolemic effects of plant sterols and stanols: do the dose-response curves diverge?. Prostaglandins Leukot Essent Fatty Acids 2011, 85:5-6.
29. Sialvera T.E., Pounis G.D., Koutelidakis A.E., et al. Phytosterols supplementation decreases plasma small and dense LDL levels in metabolic syndrome patients on a westernized type diet. Nutr Metab Cardiovasc Dis 2011, 22(10):843-848.
30. Musa-Veloso K., Poon T.H. Prostaglandins Leukot Essent Fatty Acids 2011, 85:189-193. Rebuttal to comment from Demonty.
31. Talati R., Sobieraj D.M., Makanji S.S., et al. The comparative efficacy of plant sterols and stanols on serum lipids: a systematic review and meta-analysis. J Am Diet Assoc 2010, 110:719-726.
32. Baker W.L., Baker E.L., Coleman C.I. The effect of plant sterols or stanols on lipid parameters in patients with type 2 diabetes: a meta-analysis. Diabetes Res Clin Pract 2009, 84:e33-e37.
33. Plat J., Mensink R.P. Plant stanol esters lower serum triacylglycerol concentrations via a reduced hepatic VLDL-1 production. Lipids 2009, 44:1149-1153.
34. Gagliardi A.C., Maranhao R.C., de Sousa H.P., et al. Effects of margarines and butter consumption on lipid profiles, inflammation markers and lipid transfer to HDL particles in free-living subjects with the metabolic syndrome. Eur J Clin Nutr 2010, 64:1141-1149.
35. Hernandez-Mijares A., Banuls C., Jover A., et al. Low intestinal cholesterol absorption is associated with a reduced efficacy of phytosterol esters as hypolipemic agents in patients with metabolic syndrome. Clin Nutr 2011, 30:604-609.
36. Ooi E.M., Watts G.F., Barrett P.H., et al. Dietary plant sterols supplementation does not alter lipoprotein kinetics in men with the metabolic syndrome. Asia Pac J Clin Nutr 2007, 16:624-631.
37. Lau V.W., Journoud M., Jones P.J. Plant sterols are efficacious in lowering plasma LDL and non-HDL cholesterol in hypercholesterolemic type 2 diabetic and nondiabetic persons. Am J Clin Nutr 2005, 81:1351-1358.
38. Alberti K.G., Zimmet P., Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 2005, 366:1059-1062.
39. Simonen P., Gylling H., Miettinen T.A. The validity of serum squalene and non-cholesterol sterols as surrogate markers of cholesterol synthesis and absorption in type 2 diabetes. Atherosclerosis 2008, 197:883-888.
40. Miettinen T.A., Gylling H., Nissinen M.J. The role of serum non-cholesterol sterols as surrogate markers of absolute cholesterol synthesis and absorption. Nutr Metab Cardiovasc Dis 2011, 21:765-769.
41. Moruisi K.G., Oosthuizen W., Opperman A.M. Phytosterols/stanols lower cholesterol concentrations in familial hypercholesterolemic subjects: a systematic review with meta-analysis. J Am Coll Nutr 2006, 25:41-48.
42. Sarwar N., Danesh J., Eiriksdottir G., et al. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation 2007, 115:450-458.
43. Ford E.S., Li C., Zhao G., et al. Hypertriglyceridemia and its Pharmacologic treatment among US adults. Arch Intern Med 2009, 169:572-578.
44. Derdemezis C.S., Filippatos T.D., Mikhailidis D.P., et al. Review article: effects of plant sterols and stanols beyond low-density lipoprotein cholesterol lowering. J Cardiovasc Pharmacol Ther 2010, 15:120-134.
45. Naumann E., Plat J., Kester A.D., et al. The baseline serum lipoprotein profile is related to plant stanol induced changes in serum lipoprotein cholesterol and triacylglycerol concentrations. J Am Coll Nutr 2008, 27:117-126.
46. Theuwissen E., Plat J., van der Kallen C.J., et al. Plant stanol supplementation decreases serum triacylglycerols in subjects with overt hypertriglyceridemia. Lipids 2009, 44:1131-1140.
47. Plat J., Brufau G., Dallinga-Thie G.M., et al. A plant stanol yogurt drink alone or combined with a low-dose statin lowers serum triacylglycerol and non-HDL cholesterol in metabolic syndrome patients. J Nutr 2009, 139:1143-1149.
48. Demonty I., Ras R.T., van der Knaap H.C., et al. The effect of plant sterols on serum triglyceride concentrations is dependent on baseline concentrations: a pooled analysis of 12 randomised controlled trials. Eur J Nutr 2012, [Epub ahead of print].
49. Rideout T.C., Harding S.V., Jones P.J. Consumption of plant sterols reduces plasma and hepatic triglycerides and modulates the expression of lipid regulatory genes and de novo lipogenesis in C57BL/6J mice. Mol Nutr Food Res 2010, 54(Suppl. 1):S7-S13.
50. Jackson K.G., Poppitt S.D., Minihane A.M. Postprandial lipemia and cardiovascular disease risk: Interrelationships between dietary, physiological and genetic determinants. Atherosclerosis 2012, 220:22-33.
51. AbuMweis S.S., Vanstone C.A., Lichtenstein A.H., et al. Plant sterol consumption frequency affects plasma lipid levels and cholesterol kinetics in humans. Eur J Clin Nutr 2009, 63:747-755.
52. Plat J., van Onselen E.N., van Heugten M.M., et al. Effects on serum lipids, lipoproteins and fat soluble antioxidant concentrations of consumption frequency of margarines and shortenings enriched with plant stanol esters. Eur J Clin Nutr 2000, 54:671-677.
53. Berger A., Jones P.J., Abumweis S.S. Plant sterols: factors affecting their efficacy and safety as functional food ingredients. Lipids Health Dis 2004, 3:5.
54. AbuMweis S.S., Vanstone C.A., Ebine N., et al. Intake of a single morning dose of standard and novel plant sterol preparations for 4 weeks does not dramatically affect plasma lipid concentrations in humans. J Nutr 2006, 136:1012-1016.
55. Rideout T.C., Chan Y.M., Harding S.V., et al. Low and moderate-fat plant sterol fortified soymilk in modulation of plasma lipids and cholesterol kinetics in subjects with normal to high cholesterol concentrations: report on two randomized crossover studies. Lipids Health Dis 2009, 8:45.
56. Rudkowska I., AbuMweis S.S., Nicolle C., et al. Association between non-responsiveness to plant sterol intervention and polymorphisms in cholesterol metabolism genes: a case-control study. Appl Physiol Nutr Metab 2008, 33:728-734.
57. Jakulj L., Trip M.D., Sudhop T., et al. Inhibition of cholesterol absorption by the combination of dietary plant sterols and ezetimibe: effects on plasma lipid levels. J Lipid Res 2005, 46:2692-2698.
58. Fuentes F., Lopez-Miranda J., Garcia A., et al. Basal plasma concentrations of plant sterols can predict LDL-C response to sitosterol in patients with familial hypercholesterolemia. Eur J Clin Nutr 2008, 62:495-501.
59. Casas-Agustench P., Serra M., Perez-Heras A., et al. Effects of plant sterol esters in skimmed milk and vegetable-fat-enriched milk on serum lipids and non-cholesterol sterols in hypercholesterolaemic subjects: a randomised, placebo-controlled, crossover study. Br J Nutr 2011, 1-10.
60. Carr T.P., Krogstrand K.L., Schlegel V.L., et al. Stearate-enriched plant sterol esters lower serum LDL cholesterol concentration in normo- and hypercholesterolemic adults. J Nutr 2009, 139:1445-1450.
61. Thuluva S.C., Igel M., Giesa U., et al. Ratio of lathosterol to campesterol in serum predicts the cholesterol-lowering effect of sitostanol-supplemented margarine. Int J Clin Pharmacol Ther 2005, 43:305-310.
62. Rideout T.C., Harding S.V., Mackay D., et al. High basal fractional cholesterol synthesis is associated with nonresponse of plasma LDL cholesterol to plant sterol therapy. Am J Clin Nutr 2010, 92:41-46.
63. Zhao H.L., Houweling A.H., Vanstone C.A., et al. Genetic variation in ABC G5/G8 and NPC1L1 impact cholesterol response to plant sterols in hypercholesterolemic men. Lipids 2008, 43:1155-1164.
64. Plat J., Bragt M.C., Mensink R.P. Common sequence variations in ABCG8 are related to plant sterol metabolism in healthy volunteers. J Lipid Res 2005, 46:68-75.
65. De Castro-Oros I., Pampin S., Cofan M., et al. Promoter variant -204A > C of the cholesterol 7alpha-hydroxylase gene: association with response to plant sterols in humans and increased transcriptional activity in transfected HepG2 cells. Clin Nutr 2011, 30:239-246.
66. Gylling H., Hallikainen M., Raitakari O.T., et al. Long-term consumption of plant stanol and sterol esters, vascular function and genetic regulation. Br J Nutr 2009, 101:1688-1695.
67. Myrie S.B., Mymin D., Triggs-Raine B., et al. Serum lipids, plant sterols, and cholesterol kinetic responses to plant sterol supplementation in phytosterolemia heterozygotes and control individuals. Am J Clin Nutr 2012, 95(4):837-844.
68. MacKay D.S., Jones P.J.H. Phytosterols in human nutrition: type, formulation, delivery, and physiological function. Eur J Lipid Sci Technol 2011, 113:1427-1432.
69. Denke M.A. Lack of efficacy of low-dose sitostanol therapy as an adjunct to a cholesterol-lowering diet in men with moderate hypercholesterolemia. Am J Clin Nutr 1995, 61:392-396.
70. McPherson T.B., Ostlund R.E., Goldberg A.C., et al. Phytostanol tablets reduce human LDL-cholesterol. J Pharm Pharmacol 2005, 57:889-896.
71. Rasmussen H.E., Guderian D.M., Wray C.A., et al. Reduction in cholesterol absorption is enhanced by stearate-enriched plant sterol esters in hamsters. J Nutr 2006, 136:2722-2727.
72. Normen L., Ellegard L., Janssen H.G., et al. Phytosterol and phytostanol esters are effectively hydrolysed in the gut and do not affect fat digestion in ileostomy subjects. Eur J Nutr 2006, 45:165-170.
73. Brown A.W., Hang J., Dussault P.H., et al. Plant sterol and stanol substrate specificity of pancreatic cholesterol esterase. J Nutr Biochem 2010, 21:736-740.
74. Ash M.M., Hang J., Dussault P.H., et al. Phytosterol stearate esters elicit similar responses on plasma lipids and cholesterol absorption but different responses on fecal neutral sterol excretion and hepatic free cholesterol in male Syrian hamsters. Nutr Res 2011, 31:537-543.
75. Ostlund R.E., Spilburg C.A., Stenson W.F. Sitostanol administered in lecithin micelles potently reduces cholesterol absorption in humans. Am J Clin Nutr 1999, 70:826-831.
76. Most M.M., Tulley R., Morales S., et al. Rice bran oil, not fiber, lowers cholesterol in humans. Am J Clin Nutr 2005, 81:64-68.
77. Eady S., Wallace A., Willis J., et al. Consumption of a plant sterol-based spread derived from rice bran oil is effective at reducing plasma lipid levels in mildly hypercholesterolaemic individuals. Br J Nutr 2011, 1-12.
78. Sierksma A., Weststrate J.A., Meijer G.W. Spreads enriched with plant sterols, either esterified 4,4-dimethylsterols or free 4-desmethylsterols, and plasma total- and LDL-cholesterol concentrations. Br J Nutr 1999, 82:273-282.
79. Moreau R.A., Hicks K.B. The in vitro hydrolysis of phytosterol conjugates in food matrices by mammalian digestive enzymes. Lipids 2004, 39:769-776.
80. FDA Food Labeling; health claim; phytosterols and risk of coronary heart disease; proposed rule. Fed Regist 2012, 75:76526.
81. Meijer G.W., Bressers M.A., de Groot W.A., et al. Effect of structure and form on the ability of plant sterols to inhibit cholesterol absorption in hamsters. Lipids 2003, 38:713-721.
82. Spampinato M.V., Rumboldt Z., Hosker R.J., et al. Apolipoprotein E and gray matter volume loss in patients with mild cognitive impairment and Alzheimer disease. Radiology 2011, 258:843-852.
83. Zambon D., Quintana M., Mata P., et al. Higher incidence of mild cognitive impairment in familial hypercholesterolemia. Am J Med 2010, 123:267-274.
84. Vanmierlo T., Rutten K., van Vark-van der Zee L.C., et al. Cerebral accumulation of dietary derivable plant sterols does not interfere with memory and anxiety related behavior in Abcg5-/- mice. Plant Foods Hum Nutr 2011, 66:149-156.
85. Schiepers O.J., de Groot R.H., van Boxtel M.P., et al. Consuming functional foods enriched with plant sterol or stanol esters for 85 weeks does not affect neurocognitive functioning or mood in statin-treated hypercholesterolemic individuals. J Nutr 2009, 139:1368-1373.
86. Vanmierlo T., Popp J., Kolsch H., et al. The plant sterol brassicasterol as additional CSF biomarker in Alzheimer's disease. Acta Psychiatr Scand 2011, 124:184-192.
87. Woyengo T.A., Ramprasath V.R., Jones P.J. Anticancer effects of phytosterols. Eur J Clin Nutr 2009, 63:813-820.
88. Mendilaharsu M., De Stefani E., Deneo-Pellegrini H., et al. Phytosterols and risk of lung cancer: a case-control study in Uruguay. Lung Cancer 1998, 21:37-45.
89. De Stefani E., Boffetta P., Ronco A.L., et al. Plant sterols and risk of stomach cancer: a case-control study in Uruguay. Nutr Cancer 2000, 37:140-144.
90. McCann S.E., Freudenheim J.L., Marshall J.R., et al. Risk of human ovarian cancer is related to dietary intake of selected nutrients, phytochemicals and food groups. J Nutr 2003, 133:1937-1942.
91. Normen A.L., Brants H.A., Voorrips L.E., et al. Plant sterol intakes and colorectal cancer risk in the Netherlands Cohort study on diet and cancer. Am J Clin Nutr 2001, 74:141-148.
92. Baskar A.A., Ignacimuthu S., Paulraj G.M., et al. Chemopreventive potential of beta-Sitosterol in experimental colon cancer model-an in vitro and In vivo study. BMC Complement Altern Med 2010, 10:24.
93. Awad A.B., Chinnam M., Fink C.S., et al. Beta-sitosterol activates Fas signaling in human breast cancer cells. Phytomedicine 2007, 14:747-754.
94. Awad A.B., Burr A.T., Fink C.S. Effect of resveratrol and beta-sitosterol in combination on reactive oxygen species and prostaglandin release by PC-3 cells. Prostaglandins Leukot Essent Fatty Acids 2005, 72:219-226.
95. Awad A.B., Williams H., Fink C.S. Phytosterols reduce in vitro metastatic ability of MDA-MB-231 human breast cancer cells. Nutr Cancer 2001, 40:157-164.
96. Awad A.B., Fink C.S., Williams H., et al. In vitro and in vivo (SCID mice) effects of phytosterols on the growth and dissemination of human prostate cancer PC-3 cells. Eur J Cancer Prev 2001, 10:507-513.
97. Awad A.B., Downie A., Fink C.S., et al. Dietary phytosterol inhibits the growth and metastasis of MDA-MB-231 human breast cancer cells grown in SCID mice. Anticancer Res 2000, 20:821-824.
98. Zhao Y., Chang S.K., Qu G., et al. Beta-sitosterol inhibits cell growth and induces apoptosis in SGC-7901 human stomach cancer cells. J Agric Food Chem 2009, 57:5211-5218.
99. Agren J.J., Tvrzicka E., Nenonen M.T., et al. Divergent changes in serum sterols during a strict uncooked vegan diet in patients with rheumatoid arthritis. Br J Nutr 2001, 85:137-139.
100. Jenkins D.J., Kendall C.W., Marchie A., et al. The garden of Eden-plant based diets, the genetic drive to conserve cholesterol and its implications for heart disease in the 21st century. Comp Biochem Physiol A Mol Integr Physiol 2003, 136:141-151.
101. Weingartner O., Bohm M., Laufs U. Cholesterol-lowering foods and reduction in serum cholesterol levels. JAMA 2011, 306:2217-2218.
102. Ramprasath V., Jones P.J.H., Frohlich J. Cholesterol-lowering foods and reduction in serum cholesterol levels-reply. JAMA: J Am Med Assoc 2011, 306:2218.
103. Jones P.J. Ingestion of phytosterols is not potentially hazardous. J Nutr 2007, 137:2485.
104. Fransen H.P., de Jong N., Wolfs M., et al. Customary use of plant sterol and plant stanol enriched margarine is associated with changes in serum plant sterol and stanol concentrations in humans. J Nutr 2007, 137:1301-1306.
105. Lee M.H., Lu K., Patel S.B. Genetic basis of sitosterolemia. Curr Opin Lipidol 2001, 12:141-149.
106. Salen G., Horak I., Rothkopf M., et al. Lethal atherosclerosis associated with abnormal plasma and tissue sterol composition in sitosterolemia with xanthomatosis. J Lipid Res 1985, 26:1126-1133.
107. Pandit B., Ahn G.S., Hazard S.E., et al. A detailed hapmap of the sitosterolemia locus spanning 69 kb; differences between Caucasians and African-Americans. BMC Med Genet 2006, 7:13.
108. Wang J., Joy T., Mymin D., et al. Phenotypic heterogeneity of sitosterolemia. J Lipid Res 2004, 45:2361-2367.
109. Berge K.E., von Bergmann K., Lutjohann D., et al. Heritability of plasma noncholesterol sterols and relationship to DNA sequence polymorphism in ABCG5 and ABCG8. J Lipid Res 2002, 43:486-494.
110. Boomsma D.I., Princen H.M., Frants R.R., et al. Genetic analysis of indicators of cholesterol synthesis and absorption: lathosterol and phytosterols in Dutch twins and their parents. Twin Res 2003, 6:307-314.
111. Baumgartner S., Mensink R.P., Plat J. Plant sterols and stanols in the treatment of dyslipidemia: new insights into targets and mechanisms related to cardiovascular risk. Curr Pharm Des 2011, 17:922-932.
112. Glueck C.J., Speirs J., Tracy T., et al. Relationships of serum plant sterols (phytosterols) and cholesterol in 595 hypercholesterolemic subjects, and familial aggregation of phytosterols, cholesterol, and premature coronary heart disease in hyperphytosterolemic probands and their first-degree relatives. Metabolism 1991, 40:842-848.
113. Sutherland W.H.F., Williams M.J.A., Nye E.R., et al. Associations of plasma noncholesterol sterol levels with severity of coronary artery disease. Nutr Metab Cardiovasc Dis 1998, 8:386-391.
114. Rajaratnam R.A., Gylling H., Miettinen T.A. Independent association of serum squalene and noncholesterol sterols with coronary artery disease in postmenopausal women. J Am Coll Cardiol 2000, 35:1185-1191.
115. Sudhop T., Gottwald B.M., von Bergmann K. Serum plant sterols as a potential risk factor for coronary heart disease. Metabolism 2002, 51:1519-1521.
116. Assmann G., Cullen P., Erbey J., et al. Plasma sitosterol elevations are associated with an increased incidence of coronary events in men: results of a nested case-control analysis of the prospective cardiovascular munster (PROCAM) study. Nutr Metab Cardiovasc Dis 2006, 16:13-21.
117. Matthan N.R., Pencina M., LaRocque J.M., et al. Alterations in cholesterol absorption/synthesis markers characterize Framingham offspring study participants with CHD. J Lipid Res 2009, 50:1927-1935.
118. Silbernagel G., Fauler G., Hoffmann M.M., et al. The associations of cholesterol metabolism and plasma plant sterols with all-cause and cardiovascular mortality. J Lipid Res 2010, 51:2384-2393.
119. Silbernagel G., Fauler G., Renner W., et al. The relationships of cholesterol metabolism and plasma plant sterols with the severity of coronary artery disease. J Lipid Res 2009, 50:334-341.
120. Weingartner O., Lutjohann D., Vanmierlo T., et al. Markers of enhanced cholesterol absorption are a strong predictor for cardiovascular diseases in patients without diabetes mellitus. Chem Phys Lipids 2011, 164:451-456.
121. Wilund K.R., Yu L., Xu F., et al. No association between plasma levels of plant sterols and atherosclerosis in mice and men. Arterioscler Thromb Vasc Biol 2004, 24:2326-2332.
122. Pinedo S., Vissers M.N., von Bergmann K., et al. Plasma levels of plant sterols and the risk of coronary artery disease: the prospective EPIC-norfolk population study. J Lipid Res 2007, 48:139-144.
123. Windler E., Zyriax B.C., Kuipers F., et al. Association of plasma phytosterol concentrations with incident coronary heart disease data from the Cora study, a case-control study of coronary artery disease in women. Atherosclerosis 2009, 203:284-290.
124. Miettinen T.A., Gylling H., Hallikainen M., et al. Relation of non-cholesterol sterols to coronary risk factors and carotid intima-media thickness: the cardiovascular risk in young finns Study. Atherosclerosis 2010, 209:592-597.
125. Fassbender K., Lutjohann D., Dik M.G., et al. Moderately elevated plant sterol levels are associated with reduced cardiovascular risk-the LASA study. Atherosclerosis 2008, 196:283-288.
126. Strandberg T.E., Gylling H., Tilvis R.S., et al. Serum plant and other noncholesterol sterols, cholesterol metabolism and 22-year mortality among middle-aged men. Atherosclerosis 2010, 210:282-287.
127. Escurriol V., Cofan M., Moreno-Iribas C., et al. Phytosterol plasma concentrations and coronary heart disease in the prospective Spanish EPIC cohort. J Lipid Res 2010, 51:618-624.
128. Weingartner O., Pinsdorf T., Rogacev K.S., et al. The relationships of markers of cholesterol homeostasis with carotid intima-media thickness. PLoS One 2010, 5:e13467.
129. Genser B., Silbernagel G., De Backer G., et al. Plant sterols and cardiovascular disease: a systematic review and meta-analysis. Eur Heart J 2012, 33:444-451.
130. Teupser D., Baber R., Ceglarek U., et al. Genetic regulation of serum phytosterol levels and risk of coronary artery disease. Circ Cardiovasc Genet 2010, 3:331-339.
131. Tilvis R.S., Miettinen T.A. Serum plant sterols and their relation to cholesterol absorption. Am J Clin Nutr 1986, 43:92-97.
132. Weingärtner O., Lütjohann D., Ji S., et al. Vascular effects of diet supplementation with plant sterols. J Am Coll Cardiol 2008, 51:1553-1561.
133. Plat J., Beugels I., Gijbels M.J., et al. Plant sterol or stanol esters retard lesion formation in LDL receptor-deficient mice independent of changes in serum plant sterols. J Lipid Res 2006, 47:2762-2771.
134. Moghadasian M.H., Godin D.V., McManus B.M., et al. Lack of regression of atherosclerotic lesions in phytosterol-treated apo E-deficient mice. Life Sci 1999, 64:1029-1036.
135. Moghadasian M.H., McManus B.M., Godin D.V., et al. Proatherogenic and antiatherogenic effects of probucol and phytosterols in apolipoprotein E-deficient mice: possible mechanisms of action. Circulation 1999, 99:1733-1739.
136. Moghadasian M.H., McManus B.M., Pritchard P.H., et al. "Tall oil" -derived phytosterols reduce atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 1997, 17:119-126.
137. Vaskonen T., Mervaala E., Krogerus L., et al. Supplementation of plant sterols and minerals benefits obese Zucker rats fed an atherogenic diet. J Nutr 2002, 132:231-237.
138. Ratnayake W.M., Plouffe L., L'Abbe M.R., et al. Comparative health effects of margarines fortified with plant sterols and stanols on a rat model for hemorrhagic stroke. Lipids 2003, 38:1237-1247.
139. de Jongh S., Vissers M.N., Rol P., et al. Plant sterols lower LDL cholesterol without improving endothelial function in prepubertal children with familial hypercholesterolaemia. J Inherit Metab Dis 2003, 26:343-351.
140. Hallikainen M., Lyyra-Laitinen T., Laitinen T., et al. Endothelial function in hypercholesterolemic subjects: effects of plant stanol and sterol esters. Atherosclerosis 2006, 188:425-432.
141. Hallikainen M., Lyyra-Laitinen T., Laitinen T., et al. Effects of plant stanol esters on serum cholesterol concentrations, relative markers of cholesterol metabolism and endothelial function in type 1 diabetes. Atherosclerosis 2008, 199:432-439.
142. Raitakari O.T., Salo P., Gylling H., et al. Plant stanol ester consumption and arterial elasticity and endothelial function. Br J Nutr 2008, 100:603-608.
143. Raitakari O.T., Salo P., Ahotupa M. Carotid artery compliance in users of plant stanol ester margarine. Eur J Clin Nutr 2008, 62:218-224.
144. Kelly E.R., Plat J., Mensink R.P., et al. Effects of long term plant sterol and -stanol consumption on the retinal vasculature: a randomized controlled trial in statin users. Atherosclerosis 2011, 214:225-230.
145. Vanstone C.A., Raeini-Sarjaz M., Parsons W.E., et al. Unesterified plant sterols and stanols lower LDL-cholesterol concentrations equivalently in hypercholesterolemic persons. Am J Clin Nutr 2002, 76:1272-1278.